Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
March 26, 2026
Receptor selectivity of cytisinicline: minimal 5-HT3 binding may explain lower incidence of nausea in smoking cessation therapy
Mark L Rubinstein, Cindy Jacobs
JAMA Internal Medicine
|
September 9, 2024
Cytisinicline For E-Cigarette Cessation-Reply
Nancy A Rigotti, Neal L Benowitz, Cindy Jacobs
Journal of Health Economics and Outcomes Research
|
May 25, 2026
Comparative Effectiveness of Cytisinicline and Varenicline for Smoking Cessation: A Matching-Adjusted Indirect Comparison (MAIC)
Mark Rubinstein, David Rowe, Renee Perdok, et al.
Thorax
|
September 17, 2025
Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials
Judith Prochaska, Mark Rubinstein, Renee Perdok, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
April 13, 2021
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial)
Mitchell Nides, Nancy A Rigotti, Neal Benowitz, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
October 5, 2022
A Phase I, Double-blind, Randomized, Placebo-controlled, Single Dose-escalation Study to Evaluate the Tolerability, and Safety of Cytisinicline in Adult Smokers
Cindy Jacobs, Marlene Fonseca, Nancy A Rigotti, et al.
Cancer Medicine
|
October 25, 2013
Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsen
Brent Blumenstein, Fred Saad, Sebastien Hotte, et al.
JAMA
|
July 11, 2023
Cytisinicline for Smoking Cessation: A Randomized Clinical Trial
Nancy A Rigotti, Neal L Benowitz, Judith Prochaska, et al.
JAMA Internal Medicine
|
April 21, 2025
Cytisinicline for Smoking Cessation: The ORCA Phase 3 Replication Randomized Clinical Trial
Nancy A Rigotti, Neal L Benowitz, Judith J Prochaska, et al.
JAMA Internal Medicine
|
May 6, 2024
Cytisinicline for Vaping Cessation in Adults Using Nicotine E-Cigarettes: The ORCA-V1 Randomized Clinical Trial
Nancy A Rigotti, Neal L Benowitz, Judith J Prochaska, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
March 26, 2026
Receptor selectivity of cytisinicline: minimal 5-HT3 binding may explain lower incidence of nausea in smoking cessation therapy
Mark L Rubinstein, Cindy Jacobs
JAMA Internal Medicine
|
September 9, 2024
Cytisinicline For E-Cigarette Cessation-Reply
Nancy A Rigotti, Neal L Benowitz, Cindy Jacobs
Journal of Health Economics and Outcomes Research
|
May 25, 2026
Comparative Effectiveness of Cytisinicline and Varenicline for Smoking Cessation: A Matching-Adjusted Indirect Comparison (MAIC)
Mark Rubinstein, David Rowe, Renee Perdok, et al.
Thorax
|
September 17, 2025
Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials
Judith Prochaska, Mark Rubinstein, Renee Perdok, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
April 13, 2021
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial)
Mitchell Nides, Nancy A Rigotti, Neal Benowitz, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
October 5, 2022
A Phase I, Double-blind, Randomized, Placebo-controlled, Single Dose-escalation Study to Evaluate the Tolerability, and Safety of Cytisinicline in Adult Smokers
Cindy Jacobs, Marlene Fonseca, Nancy A Rigotti, et al.
Cancer Medicine
|
October 25, 2013
Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsen
Brent Blumenstein, Fred Saad, Sebastien Hotte, et al.
JAMA
|
July 11, 2023
Cytisinicline for Smoking Cessation: A Randomized Clinical Trial
Nancy A Rigotti, Neal L Benowitz, Judith Prochaska, et al.
JAMA Internal Medicine
|
April 21, 2025
Cytisinicline for Smoking Cessation: The ORCA Phase 3 Replication Randomized Clinical Trial
Nancy A Rigotti, Neal L Benowitz, Judith J Prochaska, et al.
JAMA Internal Medicine
|
May 6, 2024
Cytisinicline for Vaping Cessation in Adults Using Nicotine E-Cigarettes: The ORCA-V1 Randomized Clinical Trial
Nancy A Rigotti, Neal L Benowitz, Judith J Prochaska, et al.
Page
of 2